Evaluation of Erectile Function in Men with Lower Urinary System Symptoms

DURSUN, MURAT; Besiroglu, Huseyin

doi:10.4274/eamr.galenos.2018.62681

Evaluation of Erectile Function in Men with Lower Urinary System Symptoms

Murat DURSUN, (Malatya Eğitim ve Araştırma Hastanesi)

Hüseyin BEŞİROĞLU (İstanbul Çatalca İlyas Çokay Devlet Hastanesi)

European Archives of Medical Research

10 1

Yıl: 2019 Cilt: 35 Sayı: 1 Sayfa Aralığı: 23 - 26 Metin Dili: İngilizce DOI: 10.4274/eamr.galenos.2018.62681 İndeks Tarihi: 01-04-2020

Evaluation of Erectile Function in Men with Lower Urinary System Symptoms

Öz:

Objective: The aim of this study was to investigate the possible relationship between erectile dysfunction (ED) and lower urinary tract symptoms(LUTS).Methods: Sixty-two patients with LUTS due to benign prostatic hyperplasia (BPH) were included in the study. Fifty-eight healthy male patients wereincluded in the study as control group. Ages, comorbidities, body mass index and previous surgeries of the patients were determined. The patientswere asked to complete the International Prostate Symptom Score and the International Index of Erectile Function (IIEF-5) questionnaires.Results: The mean age was 61.41 (41-78) years in the patients with LUTS and 62.34 (40-81) years in the control group. There was no statisticallysignificant difference between the two groups in terms of age. It was observed that LUTS severity increased significantly with age (p<0.05). When allsubjects were evaluated, there was a statistically significant relationship between LUTS and ED. When the IIEF-5 score less than 22 is accepted as ED,ED was present in 59.06% of patients with LUTS and 29.1% in asymptomatic patients. In addition, the rate of ED was significantly increased with age,as expected (p<0.05).Conclusion: The main finding in our study was that LUTS was independently associated with ED. Because of the relationship between LUTS/BPH andmale sexual dysfunction, patients presenting with any of these conditions should be routinely screened for other conditions. A better understandingof the molecular pathways beneath this relationship can help to better define clinical trials.

Anahtar Kelime:

Konular: Sağlık Bilimleri ve Hizmetleri

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Shaeer KZ, Osegbe DN, Siddiqui SH, Razzaque A, Glasser DB, Jaguste V. Prevalence of erectile dysfunction and its correlates among men attending primary care clinics in three countries: Pakistan, Egypt, and Nigeria. Int J Impot Res 2003;1:S8-14.
2. Eardley I. The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev 2013;1:3-16.
3. Oladiji F, Kayode OO, Parakoyi DB. Influence of socio- demographic characteristics on prevalence of erectile dys- function in Nigeria. Int J Impot Res 2013;25:18-23.
4. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000;12:305-11.
5. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dys- function: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-49.
6. McVary KT. Erectile dysfunction and lower urinary tract symp- toms secondary to BPH. Eur Urol 2005;47:838-45.
7. Andersson KE, de Groat WC, McVary KT, Lue TF, Maggi M, Roehrborn CG, et al. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyper- plasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn 2011;30:292-301.
8. Kirby M, Chapple C, Jackson G, Eardley I, Edwards D, Hackett G, et al. Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract 2013;67:606-18.
9. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treat- ment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64:118-40.
10. Schiff JD, Mulhall JP. The link between LUTS and ED: clinical and basic science evi- dence. J Androl 2004;25:470-8.
11. Rosen RC. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Curr Opin Urol 2006;16:11-19.
12. Huang WJ, Chen KK, Chang LS. Correlation between voiding and erectile function in patients with symptomatic benign prostatic hyperplasia. J Chin Med Assoc 2005;68:178-82.
13. Leungwattanakij S, Roongreungsilp U, Lert- sithichai P, Ratana-Olarn K. The association between erectile function and severity of lower urinary tract symptoms. J Med Assoc Thai 2005;88:91-5.
14. Marionneau N, Perrin P, Taieb C. Lower uri-12 nary tract symptoms are poorly correlated with erectile dysfunction (in French). Prog Urol 2006;16:572-7.
15. Roehrborn CG. Lower urinary tract symp- 15 toms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 in- hibitors. Rev Urol 2004;6:121-7.
16. Kaplan SA, Gonzalez RR, Te AE. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Eur Urol 2007;51:1717-23.
17. Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, et al. Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 2011;60:809-25.
18. Ikuerowo SO, Akindiji YO, Akinoso OA, Akinlusi FM, Esho JO. Association between Erectile Dysfunction and Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia in Nigerian Men. Urol Int 2008 ;80: 296-9.
19. De Nunzio C, Roehrborn CG, Andersson KE, McVary KT. Erectile Dysfunction and Lower Urinary Tract Symptoms. Eur Urol Focus 2017;3:352-63.
20. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000; 12: 305- 11.
21. Schiff JD, Mulhall JP. The link between LUTS and ED: clinical and basic science evi- dence. J Androl 2004;25:470-8.
22. Stroberg P, Boman H, Gellerstedt M, Hedelin H. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction. Scand J Urol Nephrol 2006;40:307-12.
23. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dys- function: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-49.
24. Gacci M, Andersson K-E, Chapple C, Maggi M, Mirone V, Oelke M, et al. Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2016;70:124-33.
25. De Nunzio C, Cindolo L, Gacci M, Pellegrini F, Carini M, Lombardo R, et al. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms. Urology 2014;84:1181-7.
26. McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006;97:23-8.
27. Roehrborn CG. Lower urinary tract symp- 15 toms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 in- hibitors. Rev Urol 2004;6:121-7.
28. McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G. Sildenafil ci- trate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associat- ed with benign prostatic hyperplasia: a ran- domized, double-blind trial. J Urol 2007;177:1071-7.
29. Fusco F, D’Anzeo G, Sessa A, Pace G, Rossi A, Capece M, et al. BPH/LUTS and ED: common pharmacological pathways for a common treatment. J Sex Med 2013;10:2382-93.

APA	DURSUN M, Besiroglu H (2019). Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. , 23 - 26. 10.4274/eamr.galenos.2018.62681
Chicago	DURSUN MURAT,Besiroglu Huseyin Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. (2019): 23 - 26. 10.4274/eamr.galenos.2018.62681
MLA	DURSUN MURAT,Besiroglu Huseyin Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. , 2019, ss.23 - 26. 10.4274/eamr.galenos.2018.62681
AMA	DURSUN M,Besiroglu H Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. . 2019; 23 - 26. 10.4274/eamr.galenos.2018.62681
Vancouver	DURSUN M,Besiroglu H Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. . 2019; 23 - 26. 10.4274/eamr.galenos.2018.62681
IEEE	DURSUN M,Besiroglu H "Evaluation of Erectile Function in Men with Lower Urinary System Symptoms." , ss.23 - 26, 2019. 10.4274/eamr.galenos.2018.62681
ISNAD	DURSUN, MURAT - Besiroglu, Huseyin. "Evaluation of Erectile Function in Men with Lower Urinary System Symptoms". (2019), 23-26. https://doi.org/10.4274/eamr.galenos.2018.62681

APA	DURSUN M, Besiroglu H (2019). Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. European Archives of Medical Research, 35(1), 23 - 26. 10.4274/eamr.galenos.2018.62681
Chicago	DURSUN MURAT,Besiroglu Huseyin Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. European Archives of Medical Research 35, no.1 (2019): 23 - 26. 10.4274/eamr.galenos.2018.62681
MLA	DURSUN MURAT,Besiroglu Huseyin Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. European Archives of Medical Research, vol.35, no.1, 2019, ss.23 - 26. 10.4274/eamr.galenos.2018.62681
AMA	DURSUN M,Besiroglu H Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. European Archives of Medical Research. 2019; 35(1): 23 - 26. 10.4274/eamr.galenos.2018.62681
Vancouver	DURSUN M,Besiroglu H Evaluation of Erectile Function in Men with Lower Urinary System Symptoms. European Archives of Medical Research. 2019; 35(1): 23 - 26. 10.4274/eamr.galenos.2018.62681
IEEE	DURSUN M,Besiroglu H "Evaluation of Erectile Function in Men with Lower Urinary System Symptoms." European Archives of Medical Research, 35, ss.23 - 26, 2019. 10.4274/eamr.galenos.2018.62681
ISNAD	DURSUN, MURAT - Besiroglu, Huseyin. "Evaluation of Erectile Function in Men with Lower Urinary System Symptoms". European Archives of Medical Research 35/1 (2019), 23-26. https://doi.org/10.4274/eamr.galenos.2018.62681